ASX - By Stock
|
SPL |
Re:
Viraleze reply Investor relations
|
|
joekruger
|
41 |
8.5K |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
41
|
8.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze reply Investor relations
|
|
joekruger
|
41 |
8.5K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
41
|
8.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Sanofi Annual Report 2022
|
|
joekruger
|
17 |
4.0K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
17
|
4.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Value on Starpharma's drugs (multi billions)
|
|
joekruger
|
1 |
422 |
6 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
1
|
422
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Just received invitation for Viraleze trial
|
|
joekruger
|
22 |
4.1K |
7 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
22
|
4.1K
|
7
|
|
ASX - By Stock
|
SPL |
Just received invitation for Viraleze trial
|
|
joekruger
|
22 |
4.1K |
5 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
22
|
4.1K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze no longer available in UK
|
|
joekruger
|
21 |
8.0K |
2 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
21
|
8.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze no longer available in UK
|
|
joekruger
|
21 |
8.0K |
2 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
21
|
8.0K
|
2
|
|
ASX - By Stock
|
SPL |
Viraleze no longer available in UK
|
|
joekruger
|
21 |
8.0K |
2 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
21
|
8.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
How does one vote?
|
|
joekruger
|
4 |
1.1K |
0 |
26/11/21 |
26/11/21 |
ASX - By Stock
|
4
|
1.1K
|
0
|
|
ASX - By Stock
|
SPL |
How does one vote?
|
|
joekruger
|
4 |
1.1K |
1 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is Viraleze selling like hot cakes
|
|
joekruger
|
813 |
271K |
19 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
813
|
271K
|
19
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE to be launched with LloydsPharmacy in the UK
|
|
joekruger
|
130 |
41K |
1 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
130
|
41K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE to be launched with LloydsPharmacy in the UK
|
|
joekruger
|
130 |
41K |
1 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
130
|
41K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
A disgrace
|
|
joekruger
|
52 |
16K |
7 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
52
|
16K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
congrats to all long term holders
|
|
joekruger
|
11 |
4.0K |
6 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
11
|
4.0K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21
|
|
joekruger
|
325 |
116K |
0 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
325
|
116K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21
|
|
joekruger
|
325 |
116K |
0 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
325
|
116K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Auris Medical skyrockets 480% after announcing lab-test results that show its nasal spray could prot
|
|
joekruger
|
9 |
3.1K |
4 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
9
|
3.1K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Nasal spray competition
|
|
joekruger
|
27 |
7.9K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
27
|
7.9K
|
3
|
|
ASX - By Stock
|
SPL |
Nasal spray competition
|
|
joekruger
|
27 |
7.9K |
3 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
27
|
7.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
joekruger
|
8 |
3.3K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
8
|
3.3K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
FDA decision on VIVAGEL Trail
|
|
joekruger
|
44 |
16K |
12 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
44
|
16K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 shows significant activity against coronavirus
|
|
joekruger
|
180 |
61K |
10 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
180
|
61K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 shows significant activity against coronavirus
|
|
joekruger
|
180 |
61K |
8 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
180
|
61K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 shows significant activity against coronavirus
|
|
joekruger
|
180 |
61K |
9 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
180
|
61K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Sold out
|
|
joekruger
|
47 |
19K |
10 |
16/05/19 |
16/05/19 |
ASX - By Stock
|
47
|
19K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
ADCpartners exposed
|
|
joekruger
|
3 |
1.9K |
1 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
joekruger
|
158 |
77K |
8 |
27/12/18 |
27/12/18 |
ASX - By Stock
|
158
|
77K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Not so good deal
|
|
joekruger
|
38 |
17K |
3 |
21/12/18 |
21/12/18 |
ASX - By Stock
|
38
|
17K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US VivaGel BV licensed for A$142M milestones plus royalties
|
|
joekruger
|
57 |
22K |
2 |
21/12/18 |
21/12/18 |
ASX - By Stock
|
57
|
22K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
joekruger
|
17 |
5.2K |
1 |
02/11/17 |
02/11/17 |
ASX - By Stock
|
17
|
5.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
What will Starpharma do with the up front license fee received from Global Distributor of BV formula
|
|
joekruger
|
14 |
3.8K |
2 |
28/07/17 |
28/07/17 |
ASX - By Stock
|
14
|
3.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Who knows more about Starpharma than we know
|
|
joekruger
|
18 |
7.0K |
11 |
20/06/17 |
20/06/17 |
ASX - By Stock
|
18
|
7.0K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
The Aztrazenica question
|
|
joekruger
|
15 |
5.1K |
1 |
29/12/16 |
29/12/16 |
ASX - By Stock
|
15
|
5.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Questions for the AGM
|
|
joekruger
|
40 |
8.1K |
0 |
30/11/16 |
30/11/16 |
ASX - By Stock
|
40
|
8.1K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Questions for the AGM
|
|
joekruger
|
40 |
8.1K |
3 |
24/11/16 |
24/11/16 |
ASX - By Stock
|
40
|
8.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Announcement
|
|
joekruger
|
89 |
14K |
1 |
21/07/16 |
21/07/16 |
ASX - By Stock
|
89
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Unacceptable Market Practise and Trading in Starpharma Script
|
|
joekruger
|
62 |
8.9K |
5 |
05/07/16 |
05/07/16 |
ASX - By Stock
|
62
|
8.9K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Why is FDA (US) approval for "treatment of symptoms" not an option?
|
|
joekruger
|
3 |
1.0K |
0 |
07/01/16 |
07/01/16 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
SPL |
Why is FDA (US) approval for "treatment of symptoms" not an option?
|
|
joekruger
|
3 |
1.0K |
1 |
05/01/16 |
05/01/16 |
ASX - By Stock
|
3
|
1.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
My speculation
|
|
joekruger
|
6 |
1.6K |
2 |
08/12/15 |
08/12/15 |
ASX - By Stock
|
6
|
1.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
For the newbies - what we can look forward to in the short term
|
|
joekruger
|
5 |
978 |
0 |
17/11/15 |
17/11/15 |
ASX - By Stock
|
5
|
978
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: EU Marketing Approval Granted for VivaGel BV
|
|
joekruger
|
14 |
4.7K |
2 |
24/09/15 |
24/09/15 |
ASX - By Stock
|
14
|
4.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ansell/Starpharma Dual Protect Vivagel Condoms selling through more outlets
|
|
joekruger
|
18 |
4.6K |
2 |
17/09/15 |
17/09/15 |
ASX - By Stock
|
18
|
4.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
any reason for drop?
|
|
joekruger
|
11 |
2.6K |
1 |
26/08/15 |
26/08/15 |
ASX - By Stock
|
11
|
2.6K
|
1
|
|
ASX - By Stock
|
SPL |
any reason for drop?
|
|
joekruger
|
11 |
2.6K |
1 |
24/08/15 |
24/08/15 |
ASX - By Stock
|
11
|
2.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP Docetaxel Trial Dose Exceeds Common Taxotere Dose Level
|
|
joekruger
|
12 |
4.1K |
1 |
30/04/15 |
30/04/15 |
ASX - By Stock
|
12
|
4.1K
|
1
|
|